ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
F1 Oncology Expands Operations
contractpharma
November 18, 2018Shanghai EXUMA will develop these clinical programs into multicenter trials under a centralized regulatory pathway based on the results of investigator-initiated trials (IITs) of CAR-T therapies for the treatment of metastatic renal cell carcinoma (mRCC)
Pharma Sources Insight July 2025
